Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Gillard

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivativesLaurent Provins, Bernard Christophe, Pierre Danhaive, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)Anshumali Mittal, Matthew F Martin, Laurent Provins, et al.
Respiratory Medicine|February 19, 2010
Continuous versus on-demand pharmacotherapy of allergic rhinitis: evidence and practiceGert Laekeman, Steven Simoens, Johan Buffels, et al.
Chemmedchem|February 17, 2018
5-HT<sub>7</sub> Receptor Antagonists with an Unprecedented Selectivity ProfileAli Ates, Pierre Burssens, Olivier Lorthioir, et al.
Frontiers in Molecular Neuroscience|June 10, 2022
Connectivity Mapping Using a Novel <i>sv2a</i> Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug DiscoveryYifan Zhang, Lise Heylen, Michèle Partoens, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compoundsTimothy A Lewis, Lynn Bayless, Alan J DiPesa, et al.
Nuclear Medicine and Biology|June 5, 2016
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2ASergio Estrada, Mark Lubberink, Alf Thibblin, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonistsCécile Pégurier, Philippe Collart, Pierre Danhaive, et al.
Biochemical Pharmacology|November 22, 2016
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studiesAliaa Abdelrahman, Vigneshwaran Namasivayam, Sonja Hinz, et al.
Molecular Pharmacology|March 4, 2017
The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl LeukotrienesKatharina Simon, Nicole Merten, Ralf Schröder, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|January 28, 2006
First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivativesLaurent Provins, Bernard Christophe, Pierre Danhaive, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A)Anshumali Mittal, Matthew F Martin, Laurent Provins, et al.
Respiratory Medicine|February 19, 2010
Continuous versus on-demand pharmacotherapy of allergic rhinitis: evidence and practiceGert Laekeman, Steven Simoens, Johan Buffels, et al.
Chemmedchem|February 17, 2018
5-HT<sub>7</sub> Receptor Antagonists with an Unprecedented Selectivity ProfileAli Ates, Pierre Burssens, Olivier Lorthioir, et al.
Frontiers in Molecular Neuroscience|June 10, 2022
Connectivity Mapping Using a Novel <i>sv2a</i> Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug DiscoveryYifan Zhang, Lise Heylen, Michèle Partoens, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compoundsTimothy A Lewis, Lynn Bayless, Alan J DiPesa, et al.
Nuclear Medicine and Biology|June 5, 2016
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2ASergio Estrada, Mark Lubberink, Alf Thibblin, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonistsCécile Pégurier, Philippe Collart, Pierre Danhaive, et al.
Biochemical Pharmacology|November 22, 2016
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studiesAliaa Abdelrahman, Vigneshwaran Namasivayam, Sonja Hinz, et al.
Molecular Pharmacology|March 4, 2017
The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl LeukotrienesKatharina Simon, Nicole Merten, Ralf Schröder, et al.
Pageof 6